323 related articles for article (PubMed ID: 23300833)
1. Identification of novel imidazo[1,2-a]pyridine inhibitors targeting M. tuberculosis QcrB.
Abrahams KA; Cox JA; Spivey VL; Loman NJ; Pallen MJ; Constantinidou C; Fernández R; Alemparte C; Remuiñán MJ; Barros D; Ballell L; Besra GS
PLoS One; 2012; 7(12):e52951. PubMed ID: 23300833
[TBL] [Abstract][Full Text] [Related]
2. Biochemical and structural characterization of mycobacterial aspartyl-tRNA synthetase AspS, a promising TB drug target.
Gurcha SS; Usha V; Cox JA; Fütterer K; Abrahams KA; Bhatt A; Alderwick LJ; Reynolds RC; Loman NJ; Nataraj V; Alemparte C; Barros D; Lloyd AJ; Ballell L; Hobrath JV; Besra GS
PLoS One; 2014; 9(11):e113568. PubMed ID: 25409504
[TBL] [Abstract][Full Text] [Related]
3. Arylvinylpiperazine Amides, a New Class of Potent Inhibitors Targeting QcrB of Mycobacterium tuberculosis.
Foo CS; Lupien A; Kienle M; Vocat A; Benjak A; Sommer R; Lamprecht DA; Steyn AJC; Pethe K; Piton J; Altmann KH; Cole ST
mBio; 2018 Oct; 9(5):. PubMed ID: 30301850
[TBL] [Abstract][Full Text] [Related]
4. Tetrahydropyrazolo[1,5-a]pyrimidine-3-carboxamide and N-benzyl-6',7'-dihydrospiro[piperidine-4,4'-thieno[3,2-c]pyran] analogues with bactericidal efficacy against Mycobacterium tuberculosis targeting MmpL3.
Remuiñán MJ; Pérez-Herrán E; Rullás J; Alemparte C; Martínez-Hoyos M; Dow DJ; Afari J; Mehta N; Esquivias J; Jiménez E; Ortega-Muro F; Fraile-Gabaldón MT; Spivey VL; Loman NJ; Pallen MJ; Constantinidou C; Minick DJ; Cacho M; Rebollo-López MJ; González C; Sousa V; Angulo-Barturen I; Mendoza-Losana A; Barros D; Besra GS; Ballell L; Cammack N
PLoS One; 2013; 8(4):e60933. PubMed ID: 23613759
[TBL] [Abstract][Full Text] [Related]
5. 3-Aryl-substituted imidazo[1,2-a]pyridines as antituberculosis agents.
Karale UB; Shinde AU; Babar DA; Sangu KG; Vagolu SK; Eruva VK; Jadav SS; Misra S; Dharmarajan S; Rode HB
Arch Pharm (Weinheim); 2021 Oct; 354(10):e2000419. PubMed ID: 34185337
[TBL] [Abstract][Full Text] [Related]
6. New 2-Ethylthio-4-methylaminoquinazoline derivatives inhibiting two subunits of cytochrome bc1 in Mycobacterium tuberculosis.
Lupien A; Foo CS; Savina S; Vocat A; Piton J; Monakhova N; Benjak A; Lamprecht DA; Steyn AJC; Pethe K; Makarov VA; Cole ST
PLoS Pathog; 2020 Jan; 16(1):e1008270. PubMed ID: 31971990
[TBL] [Abstract][Full Text] [Related]
7. Identification of 4-Amino-Thieno[2,3-
Harrison GA; Mayer Bridwell AE; Singh M; Jayaraman K; Weiss LA; Kinsella RL; Aneke JS; Flentie K; Schene ME; Gaggioli M; Solomon SD; Wildman SA; Meyers MJ; Stallings CL
mSphere; 2019 Sep; 4(5):. PubMed ID: 31511370
[TBL] [Abstract][Full Text] [Related]
8. Activity of 5-chloro-pyrazinamide in mice infected with Mycobacterium tuberculosis or Mycobacterium bovis.
Ahmad Z; Tyagi S; Minkowsk A; Almeida D; Nuermberger EL; Peck KM; Welch JT; Baughn AS; Jacobs WR; Grosset JH
Indian J Med Res; 2012 Nov; 136(5):808-14. PubMed ID: 23287128
[TBL] [Abstract][Full Text] [Related]
9. Pyrazolo[1,5- a]pyridine Inhibitor of the Respiratory Cytochrome bcc Complex for the Treatment of Drug-Resistant Tuberculosis.
Lu X; Williams Z; Hards K; Tang J; Cheung CY; Aung HL; Wang B; Liu Z; Hu X; Lenaerts A; Woolhiser L; Hastings C; Zhang X; Wang Z; Rhee K; Ding K; Zhang T; Cook GM
ACS Infect Dis; 2019 Feb; 5(2):239-249. PubMed ID: 30485737
[TBL] [Abstract][Full Text] [Related]
10. Loperamide exerts a direct bactericidal effect against M. tuberculosis, M. bovis, M. terrae and M. smegmatis.
Barrientos OM; Juárez E; Gonzalez Y; Castro-Villeda DA; Torres M; Guzmán-Beltrán S
Lett Appl Microbiol; 2021 Mar; 72(3):351-356. PubMed ID: 33220096
[TBL] [Abstract][Full Text] [Related]
11. In vitro anti-mycobacterial activity of selected medicinal plants against Mycobacterium tuberculosis and Mycobacterium bovis strains.
Gemechu A; Giday M; Worku A; Ameni G
BMC Complement Altern Med; 2013 Oct; 13():291. PubMed ID: 24168665
[TBL] [Abstract][Full Text] [Related]
12. Imidazopyridine Compounds Inhibit Mycobacterial Growth by Depleting ATP Levels.
O'Malley T; Alling T; Early JV; Wescott HA; Kumar A; Moraski GC; Miller MJ; Masquelin T; Hipskind PA; Parish T
Antimicrob Agents Chemother; 2018 Jun; 62(6):. PubMed ID: 29632008
[TBL] [Abstract][Full Text] [Related]
13. Synthesis, biological evaluation and molecular docking study of some novel indole and pyridine based 1,3,4-oxadiazole derivatives as potential antitubercular agents.
Desai NC; Somani H; Trivedi A; Bhatt K; Nawale L; Khedkar VM; Jha PC; Sarkar D
Bioorg Med Chem Lett; 2016 Apr; 26(7):1776-83. PubMed ID: 26920799
[TBL] [Abstract][Full Text] [Related]
14. OPC-67683, a nitro-dihydro-imidazooxazole derivative with promising action against tuberculosis in vitro and in mice.
Matsumoto M; Hashizume H; Tomishige T; Kawasaki M; Tsubouchi H; Sasaki H; Shimokawa Y; Komatsu M
PLoS Med; 2006 Nov; 3(11):e466. PubMed ID: 17132069
[TBL] [Abstract][Full Text] [Related]
15. Arrival of Imidazo[2,1-b]thiazole-5-carboxamides: Potent Anti-tuberculosis Agents That Target QcrB.
Moraski GC; Seeger N; Miller PA; Oliver AG; Boshoff HI; Cho S; Mulugeta S; Anderson JR; Franzblau SG; Miller MJ
ACS Infect Dis; 2016 Jun; 2(6):393-8. PubMed ID: 27627627
[TBL] [Abstract][Full Text] [Related]
16. Design, synthesis, and evaluation of new 2-(quinoline-4-yloxy)acetamide-based antituberculosis agents.
Borsoi AF; Paz JD; Abbadi BL; Macchi FS; Sperotto N; Pissinate K; Rambo RS; Ramos AS; Machado D; Viveiros M; Bizarro CV; Basso LA; Machado P
Eur J Med Chem; 2020 Apr; 192():112179. PubMed ID: 32113048
[TBL] [Abstract][Full Text] [Related]
17. Activity of 2-(quinolin-4-yloxy)acetamides in Mycobacterium tuberculosis clinical isolates and identification of their molecular target by whole-genome sequencing.
Subtil FT; Villela AD; Abbadi BL; Rodrigues-Junior VS; Bizarro CV; Timmers LFSM; de Souza ON; Pissinate K; Machado P; López-Gavín A; Tudó G; González-Martín J; Basso LA; Santos DS
Int J Antimicrob Agents; 2018 Mar; 51(3):378-384. PubMed ID: 28843821
[TBL] [Abstract][Full Text] [Related]
18. Detection of a streptomycin-resistant Mycobacterium bovis strain through antitubercular drug susceptibility testing of Tunisian Mycobacterium tuberculosis complex isolates from cattle.
Djemal SE; Camperio C; Armas F; Siala M; Smaoui S; Messadi-Akrout F; Gdoura R; Marianelli C
BMC Vet Res; 2018 Sep; 14(1):296. PubMed ID: 30268120
[TBL] [Abstract][Full Text] [Related]
19. Resazurin reduction assays for screening of anti-tubercular compounds against dormant and actively growing Mycobacterium tuberculosis, Mycobacterium bovis BCG and Mycobacterium smegmatis.
Taneja NK; Tyagi JS
J Antimicrob Chemother; 2007 Aug; 60(2):288-93. PubMed ID: 17586560
[TBL] [Abstract][Full Text] [Related]
20. Anti-tubercular screening of natural products from Colombian plants: 3-methoxynordomesticine, an inhibitor of MurE ligase of Mycobacterium tuberculosis.
Guzman JD; Gupta A; Evangelopoulos D; Basavannacharya C; Pabon LC; Plazas EA; Muñoz DR; Delgado WA; Cuca LE; Ribon W; Gibbons S; Bhakta S
J Antimicrob Chemother; 2010 Oct; 65(10):2101-7. PubMed ID: 20719764
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
